Wensen Chen1, Quan Cao1, Songqin Li1, Huifen Li1, Weihong Zhang1. 1. 1 Department of Infection Management Office, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China ; 2 Department of Critical Care Medicine, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Abstract
OBJECTIVE: Ventilator associated pneumonia (VAP) is the most important nosocomial infection in intensive care units (ICUs). Our objective was to assess whether daily bathing with chlorhexidine gluconate (CHG) would significantly result in the reduction of VAP. MATERIALS AND METHODS: Meta-analysis of randomized controlled trials (RCTs) and quasi-experimental studies were conducted. The setting are medical, surgical, trauma, and combined medical-surgical ICUs. The patients are adult. We searched electronic search engine (PubMed), Embase and the Cochrane Central Register database for all published studies related to the application of daily CHG bathing with VAP risk. RESULTS: In all, six articles reporting a total of 27,638 ventilator-days met the inclusion criteria; 132 patients in the CHG arm developed a VAP (13,349 ventilator-days), compared with 188 patients in the control arm (14,289 ventilator-days). Daily bathing with CHG was significantly associated with decreased incidence risk of VAP [relative risk (RR): 0.73, 95% confidence interval (CI): 0.57-0.92, I(2)=0%]. In the subgroup analysis, we found that daily bathing with 2% CHG impregnated cloths or wipes would reduce the incidence risk of VAP among before-and-after studies (pooled RR: 0.73, 95% CI: 0.57-0.93). CONCLUSIONS: The application of daily bathing with CHG would decrease incidence risk of VAP, which would be an important complementary intervention to barrier precautions.
OBJECTIVE: Ventilator associated pneumonia (VAP) is the most important nosocomial infection in intensive care units (ICUs). Our objective was to assess whether daily bathing with chlorhexidine gluconate (CHG) would significantly result in the reduction of VAP. MATERIALS AND METHODS: Meta-analysis of randomized controlled trials (RCTs) and quasi-experimental studies were conducted. The setting are medical, surgical, trauma, and combined medical-surgical ICUs. The patients are adult. We searched electronic search engine (PubMed), Embase and the Cochrane Central Register database for all published studies related to the application of daily CHG bathing with VAP risk. RESULTS: In all, six articles reporting a total of 27,638 ventilator-days met the inclusion criteria; 132 patients in the CHG arm developed a VAP (13,349 ventilator-days), compared with 188 patients in the control arm (14,289 ventilator-days). Daily bathing with CHG was significantly associated with decreased incidence risk of VAP [relative risk (RR): 0.73, 95% confidence interval (CI): 0.57-0.92, I(2)=0%]. In the subgroup analysis, we found that daily bathing with 2% CHG impregnated cloths or wipes would reduce the incidence risk of VAP among before-and-after studies (pooled RR: 0.73, 95% CI: 0.57-0.93). CONCLUSIONS: The application of daily bathing with CHG would decrease incidence risk of VAP, which would be an important complementary intervention to barrier precautions.
Authors: John C O'Horo; Germana L M Silva; L Silvia Munoz-Price; Nasia Safdar Journal: Infect Control Hosp Epidemiol Date: 2012-01-25 Impact factor: 3.254
Authors: Kyle J Popovich; Bala Hota; Robert Hayes; Robert A Weinstein; Mary K Hayden Journal: Intensive Care Med Date: 2010-03-06 Impact factor: 17.440
Authors: Marie-Laurence Lambert; Carl Suetens; Anne Savey; Mercedes Palomar; Michael Hiesmayr; Ingrid Morales; Antonella Agodi; Uwe Frank; Karl Mertens; Martin Schumacher; Martin Wolkewitz Journal: Lancet Infect Dis Date: 2010-12-02 Impact factor: 25.071
Authors: Timothy D Girard; John P Kress; Barry D Fuchs; Jason W W Thomason; William D Schweickert; Brenda T Pun; Darren B Taichman; Jan G Dunn; Anne S Pohlman; Paul A Kinniry; James C Jackson; Angelo E Canonico; Richard W Light; Ayumi K Shintani; Jennifer L Thompson; Sharon M Gordon; Jesse B Hall; Robert S Dittus; Gordon R Bernard; E Wesley Ely Journal: Lancet Date: 2008-01-12 Impact factor: 79.321
Authors: Shruti K Gohil; Raveena Singh; Justin Chang; Adrijana Gombosev; Tom Tjoa; Matthew Zahn; Patti Steger; Susan S Huang Journal: Am J Infect Control Date: 2017-07-27 Impact factor: 2.918
Authors: Tjallie I I van der Kooi; Hendriek Boshuizen; Jan C Wille; Sabine C de Greeff; Jaap T van Dissel; Annelot F Schoffelen; Rolina D van Gaalen Journal: PLoS One Date: 2019-06-20 Impact factor: 3.240